PetVivo Holdings (PETV) Capital Expenditures (2016 - 2026)
PetVivo Holdings' Capital Expenditures came in at $12,370 for fiscal Q1 2027 (quarter ended Jun 30, 2026).
Powered by 
Analysis
PetVivo Holdings (PETV) Capital Expenditures (2016 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, PetVivo Holdings reported Capital Expenditures of $28,379; for FY2026 (ended Mar 31, 2026), it was $7,734, down 87.8% from FY2025.
- Capital Expenditures has declined in each of the last three fiscal years, with a five-year compound annual growth rate of -44.0% (FY2021 to FY2026).
- Going back by fiscal year, Capital Expenditures was $63,434 in FY2025 (-79.5%), $309,104 in FY2024 (-27.1%), $423,934 in FY2023 (+175.2%) and $154,030 in FY2022 (+9.5%).
- The fiscal Q1 2027 figure represents the highest quarterly Capital Expenditures since fiscal Q4 2025.
- The fastest year-over-year change in Capital Expenditures over five years came in fiscal Q3 2023 (growth of 180.9%), and the weakest in fiscal Q2 2025 (a decline of 92.6%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 3.18 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 1.36 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 301.00 Mn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 1.04 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | -3.30 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 587.00 Mn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 237.00 Mn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 573.00 Mn |
| 10 | PetVivo Holdings | 19.55 Mn | 18.29 Mn | 223,317.00 | 12,370.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12,370.00 |
| Dec 31, 2025 | -5,195.00 |
| Mar 31, 2025 | 21,204.00 |
| Dec 31, 2024 | 23,632.00 |
| Sep 30, 2024 | 3,420.00 |
| Jun 30, 2024 | 15,178.00 |
| Mar 31, 2024 | 29,302.00 |
| Dec 31, 2023 | 186,184.00 |
| Sep 30, 2023 | 46,224.00 |
| Jun 30, 2023 | 47,394.00 |
| Mar 31, 2023 | 130,083.00 |
| Dec 31, 2022 | 210,285.00 |
| Sep 30, 2022 | 58,669.00 |
| Jun 30, 2022 | 24,897.00 |
| Mar 31, 2022 | 62,122.00 |
| Dec 31, 2021 | 74,849.00 |
| Mar 31, 2021 | 22,261.00 |
| Dec 31, 2020 | 36,550.00 |
| Sep 30, 2020 | 40,638.00 |
| Jun 30, 2020 | 41,236.00 |
API Access
PetVivo Holdings Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=PETV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "PETV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=PETV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();